Human umbilical cord blood-derived serum for culturing the supportive feeder cells of human pluripotent stem cell lines

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Rungsiwiwut, Ruttachuk ^a   Ingrungruanglert, Praewphan ^a   Numchaisrika, Pranee ^a   Virutamasen, Pramuan ^a   Phermthai, Tatsanee ^b   Pruksananonda, Kamthorn ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA1;

ACTIVIN A GENE; ARTICLE; BMP4 GENE; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; FEEDER CELL; FETAL BOVINE SERUM; FGF2 GENE; FIBROBLAST CULTURE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD BLOOD DERIVED SERUM; KARYOTYPE; NANOG GENE; OCT 4 GENE; PLURIPOTENT STEM CELL LINE; PRIORITY JOURNAL; REX1 GENE; SERUM; SKIN FIBROBLAST; STEM CELL CULTURE; SUPPLEMENTATION; TGF BETA1 GENE; UTF GENE;

EID: 84956964976     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/4626048     Document Type: Article

References (36)

1. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., "Embryonic stem cell lines derived from human blastocysts, " Science, vol. 282, no. 5391, pp. 1145-1147, 1998.
2. K. Takahashi, K. Tanabe, M. Ohnuki et al., "Induction of pluripotent stem cells from adult human fibroblasts by defined factors, " Cell, vol. 131, no. 5, pp. 861-872, 2007.
3. U. Ben-David and N. Benvenisty, "The tumorigenicity of human embryonic and induced pluripotent stem cells, " Nature Reviews Cancer, vol. 11, no. 4, pp. 268-277, 2011.
4. E. S. Philonenko, M. V. Shutova, I. V. Chestkov, M. A. Lagarkova, and S. L. Kiselev, "Current progress and potential practical application for human pluripotent stem cells, " International Review of Cell andMolecular Biology, vol. 292, pp. 153-196, 2011.
5. G. Meng, S. Liu, and D. E. Rancourt, "Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xenofree conditions, " Stem Cells and Development, vol. 21, no. 11, pp. 2036-2048, 2012.
6. X. Ma, H. Li, S. Xin, Y. Ma, and T. Ouyang, "Human amniotic fluid stem cells support undifferentiated propagation and pluripotency of human embryonic stem cell without b-FGF in a density dependent manner, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 8, pp. 4661-4673, 2014.
7. S. Saxena, M. Hanwate, K. Deb, V. Sharma, and S. Totey, "FGF2 secreting human fibroblast feeder cells: a novel culture system for human embryonic stem cells, " Molecular Reproduction and Development, vol. 75, no. 10, pp. 1523-1532, 2008.
8. C. Unger, S. Gao, M. Cohen et al., "Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells, " Human Reproduction, vol. 24, no. 10, pp. 2567-2581, 2009.
9. C. Ellerstrom, R. Strehl, K. Moya et al., "Derivation of a xenofree human embryonic stem cell line, " Stem Cells, vol. 24, no. 10, pp. 2170-2176, 2006.
10. G. Meng, S. Liu, X. Li, R. Krawetz, and D. E. Rancourt, "Extracellularmatrix isolated fromforeskin fibroblasts supports long-term xeno-free human embryonic stem cell culture, " Stem Cells and Development, vol. 19, no. 4, pp. 547-556, 2010.
11. P. Shetty, K. Bharucha, and V. Tanavde, "Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells, " Cell Biology International, vol. 31, no. 3, pp. 293-298, 2007.
12. A. Kocaoemer, S. Kern, H. Kluter, and K. Bieback, "Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue, " Stem Cells, vol. 25, no. 5, pp. 1270-1278, 2007.
13. J. Jung, N. Moon, J.-Y. Ahn et al., "Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential, " StemCells and Development, vol. 18, no. 4, pp. 559-571, 2009.
14. N. Prathalingam, L. Ferguson, L. Young et al., "Production and validation of a good manufacturing practice grade human fibroblast line for supporting human embryonic stem cell derivation and culture, " Stem Cell Research andTherapy, vol. 3, no. 2, article 12, 2012.
15. S. E. Tannenbaum, T. Turetsky, O. Singer et al., "Derivation of xeno-free and GMP-grade human embryonic stem cells- platforms for future clinical applications, " PLoS ONE, vol. 7, no. 6, Article ID e35325, 2012.
16. T. Phermthai, Y. Odglun, P. Chuenwattana, S. Julavijitphong, V. Titapant, and C. Vantanasiri, "Successful derivation and characteristics of xeno-free mesenchymal stem cell lines from human amniotic fluid generated under allogenic cord blood serum supplementation, " Tissue Engineering and Regenerative Medicine, vol. 8, no. 2, pp. 216-223, 2011.
17. S. Julavijitphong, S. Wichitwiengrat, N. Tirawanchai, P. Ruangvutilert, C. Vantanasiri, and T. Phermthai, "A xeno-free culture method that enhances Whartons jelly mesenchymal stromal cell culture efficiency over traditional animal serumsupplemented cultures, " Cytotherapy, vol. 16, no. 5, pp. 683-691, 2014.
18. S. Vuoristo, S. Toivonen, J. Weltner et al., "A novel feeder-free culture system for human pluripotent stem cell culture and induced pluripotent stem cell derivation, " PLoS ONE, vol. 8, no. 10, Article ID e76205, 2013.
19. P. Catalina, R. Montes, G. Ligero et al., "Human ESCs predisposition to karyotypic instability: is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?" Molecular Cancer, vol. 7, article 76, 2008.
20. T. E. Ludwig, M. E. Levenstein, J. M. Jones et al., "Derivation of human embryonic stem cells in defined conditions, " Nature Biotechnology, vol. 24, no. 2, pp. 185-187, 2006.
21. L. Eiselleova, I. Peterkova, J. Neradil, I. Slaninova, A. Hampl, and P. Dvorak, "Comparative study ofmouse and human feeder cells for human embryonic stem cells, " International Journal of Developmental Biology, vol. 52, no. 4, pp. 353-363, 2008.
22. Y.-T. Shi, Y.-Z. Huang, Fan-Tang, and J.-X. Chu, "Mouse embryonic stem cell-derived feeder cells support the growth of their own mouse embryonic stem cells, " Cell Biology International, vol. 30, no. 12, pp. 1041-1047, 2006.
23. O. Hovatta, M. Mikkola, K. Gertow et al., "A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stemcells, " Human Reproduction, vol. 18, no. 7, pp. 1404-1409, 2003.
24. J. Inzunza, K. Gertow, M. A. Stromberg et al., "Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells, " Stem Cells, vol. 23, no. 4, pp. 544-549, 2005.
25. K. Pruksananonda, R. Rungsiwiwut, P. Numchaisrika, V. Ahnonkitpanit, N. Isarasena, and P. Virutamasen, "Eighteenyear cryopreservation does not negatively affect the pluripotency of human embryos: evidence from embryonic stem cell derivation, " BioResearch Open Access, vol. 1, no. 4, pp. 166-173, 2012.
26. S. D. Schwartz, J.-P. Hubschman, G. Heilwell et al., "Embryonic stem cell trials for macular degeneration: a preliminary report, " The Lancet, vol. 379, no. 9817, pp. 713-720, 2012.
27. S. D. Schwartz, C. D. Regillo, B. L. Lam et al., "Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardts macular dystrophy: follow-up of two open-label phase 1/2 studies, " The Lancet, vol. 385, no. 9967, pp. 509-516, 2015.
28. J. Suchanek, T. S. Kleplova, M. Kapitan, and T. Soukup, "The effect of fetal calf serum on human dental pulp stem cells, " Acta Medica, vol. 56, no. 4, pp. 142-149, 2013.
29. P. Salehinejad, N. B. Alitheen, S. N. Nematollahi-Mahani et al., "Effect of culture media on expansion properties of human umbilical cord matrix-derived mesenchymal cells, " Cytotherapy, vol. 14, no. 8, pp. 948-953, 2012.
30. H. E. Broxmeyer, L. Benninger, M. Yip-Schneider, and S. E. Braun, "Commentary: a rapid proliferation assay for unknown co-stimulating factors in cord blood plasma possibly involved in enhancement of in vitro expansion and replating capacity of human hematopoietic stem/progenitor cells, " Blood Cells, vol. 20, no. 2-3, pp. 492-497, 1994.
31. K. Bieback, V. A.-T. Ha, A. Hecker et al., "Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements, " Tissue Engineering Part A, vol. 16, no. 11, pp. 3467-3484, 2010.
32. H. Ueyama, T. Horibe, S. Hinotsu, et al., "Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions, " Journal of Cellular and Molecular Medicine, vol. 16, no. 1, pp. 72-82, 2012.
33. N. Y. K. Li, F. Chen, F. G. Dikkers, and S. L. Thibeault, "Dose-dependent effect of mitomycin C on human vocal fold fibroblasts, " Head and Neck, vol. 36, no. 3, pp. 401-410, 2014.
34. M. K. Mamidi, R. Pal, N. A. B. Mori et al., "Co-culture of mesenchymal-like stromal cells derived from human foreskin permits long term propagation and differentiation of human embryonic stem cells, " Journal of Cellular Biochemistry, vol. 112, no. 5, pp. 1353-1363, 2011.
35. D. Soteriou, B. Iskender, A. Byron et al., "Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance, " Journal of Biological Chemistry, vol. 288, no. 26, pp. 18716-18731, 2013.
36. P. Ingrungruanglert, P. Amarinthnukrowh, R. Rungsiwiwut et al., "Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation, "Thrombosis and Haemostasis, vol. 113, no. 4, pp. 792-805, 2015.